Activation of p53 pathway by Nutlin-3a inhibits the expression of the therapeutic target α5 integrin in colon cancer cells-Reference-Cited by-同舟云学术

Activation of p53 pathway by Nutlin-3a inhibits the expression of the therapeutic target α5 integrin in colon cancer cells

Published:2013-08 Issue:2 Volume:336 Page:307-318
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Janouskova Hana,Ray Anne-Marie,Noulet Fanny,Lelong-Rebel Isabelle,Choulier Laurence,Schaffner Florence,Lehmann Maxime,Martin Sophie,Teisinger Jan,Dontenwill Monique

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference41 articles.

1. Regulation of colon cancer recurrence and development of therapeutic strategies;Kanwar;World J. Gastrointest. Pathophysiol.,2012

2. Integrins in cancer: biological implications and therapeutic opportunities;Desgrosellier;Nat. Rev. Cancer,2010

3. Integrin receptors and ECM proteins involved in preferential adhesion of colon carcinoma cells to lung cells;Karmakar;Cancer Lett.,2003

4. Alteration of expression in integrin beta 1-subunit correlates with invasion and metastasis in colorectal cancer;Fujita;Cancer Lett.,1995

5. Role of α5β1 integrin in determining malignant properties of colon carcinoma cells;Gong;Cell Growth Differ.,1997

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a prognostic model for anoikis and identifies hub genes in hepatocellular carcinoma;Scientific Reports;2023-09-07

2. Pixel-by-pixel autofluorescence corrected FRET in fluorescence microscopy improves accuracy for samples with spatially varied autofluorescence to signal ratio;Scientific Reports;2023-02-20

3. Integrin β1 in Pancreatic Cancer: Expressions, Functions, and Clinical Implications;Cancers;2022-07-11

4. p53 Signaling on Microenvironment and Its Contribution to Tissue Chemoresistance;Membranes;2022-02-09

5. Matrix stiffening and acquired resistance to chemotherapy: concepts and clinical significance;British Journal of Cancer;2022-02-05